As a former nurse, I have given hundreds of injections of all types, at all possible injection sites, for innumerous reasons and with differing patient tolerances
Additionally, a 2024 commentary in Nature Reviews Endocrinology suggested that the future of GLP-1 use may be individualized dosing , guided by biomarker response and patient goals
These providers typically specialize in weight management and have experience with GLP-1 therapy protocols
### Tirzepatide: The Injectable Dual Agonist Tirzepatide (Zepbound/Mounjaro) remains the most effective GLP-1-based medication for weight loss, with 20-22.5% body weight reduction in the SURMOUNT-1 trial
Your furry family members have sensitivities and preferences just like we do
A new analysis of the SURMOUNT clinical trials reveals that the medicine, administered as a once-weekly injection, leads to significant weight reduction